Showing results (91-100 of 98) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
International Journal of Antimicrobial Agents|January 21, 2015
In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in ChinaQiwen Yang, Hui Zhang, Jingwei Cheng, et al.Diagnostic Microbiology and Infectious Disease|October 25, 2016
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in ChinaKang Liao, Yili Chen, Menghe Wang, et al.BMC Infectious Diseases|March 8, 2017
Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014Qiwen Yang, Hui Zhang, Yao Wang, et al.Journal of Medical Microbiology|June 7, 2013
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in ChinaQiwen Yang, Hui Zhang, Yao Wang, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 10, 2014
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trialJun Cheng, Yuming Wang, Jinlin Hou, et al.Virology Journal|October 30, 2016
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patientsSong Yang, Huichun Xing, Yuming Wang, et al.Journal of Clinical and Translational Hepatology|October 15, 2019
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in ChinaXiaoyuan Xu, Bo Feng, Yujuan Guan, et al.Journal of Clinical and Translational Hepatology|January 10, 2020
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis BShan Shan, Hong You, Junqi Niu, et al.Pageof 10